Perennial Allergic Rhinoconjunctivitis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Perennial Allergic Rhinoconjunctivitis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 3

NCT07348302

Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df

The goal of this clinical trial is to learn if MM09 works to treat patients allergic to house mites, displaying rhinitis/rhinoconjunctivitis with or without mil…

Argentina736 participantsStarted 2025-04-02

Treatment: Allergen Immunotherapy Extract

All recent trials (28 shown)

CompletedNot Applicable

NCT07427576

Retrospective Study Evaluating the Effectiveness and Safety of Immunotherapy With Clustoid Max Forte

House dust mites are the main source of allergies in indoor environments. They are predominant in coastal areas, with the Canary Islands being the autonomous co…

Spain140 participantsStarted 2025-03-31

Treatment: Clustoid® Max Forte

Active — Not RecruitingPhase 3

NCT06920771

A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,0…

Rationale: Allergic rhinitis/rhinoconjunctivitis (ARC) is a global health problem, affecting 10-25% of the population. Allergen-specific immunotherapy is the on…

Bulgaria552 participantsStarted 2024-09-09

Treatment: PURETHAL Mites 50,000 AUeq/ml, Biological/Vaccine: Placebo

Perennial Allergic Rhinoconjunctivitis

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df

All recent trials (28 shown)

Retrospective Study Evaluating the Effectiveness and Safety of Immunotherapy With Clustoid Max Forte

A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,0…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df

All recent trials (28 shown)

Retrospective Study Evaluating the Effectiveness and Safety of Immunotherapy With Clustoid Max Forte

A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,0…

Efficacy and Safety Evaluation for the Treatment of Asthma and Allergic Rhinitis/Rhinoconjunctivitis

Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen Extract

Efficacy and Safety Evaluation for the Treatment of HDM Induced Allergic Asthma and Rhinitis/Rhinoconjunctivitis

Long-term Effect of a 3-month Supplementation With Holo-BLG on House Dust Mite Induced Allergic Rhinoconjunctivitis

DYmista NAsal Spray in CHInese Patients

Impact of a Novel Immune Modulating Dietary Supplement on House Dust Mite Induced Allergic Rhinoconjunctivitis

Non-interventional Study to Assess the Tolerability and the Safety Profile of SCIT Therapy With Acarovac® Hausstaubmilbe

Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rh…

A Dose-Ranging Study of the Safety and Effectiveness of MK-8237 in the Treatment of House Dust Mite (HDM) Induced Allerg…

Safety and Clinical Tolerability of hdmASIT+TM Peptides Administered in HDM-induced Allergic Patients

A Study of SCH 697243 in Participants With Grass Pollen Allergy Symptoms, With or Without Asthma (P08067)

SUBLIVAC FIX Mite Mixture Dose Tolerability Study

Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children

Safety and Efficacy of House Dust Mite Allergoid in the Treatment of Bronchial Asthma

ToleroMune House Dust Mite Follow on Study

Efficacy and Safety From a High-dosed Sublingual Grass Pollen Preparation

A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis

Safety and Efficacy of House Dust Mite Allergen Extract in the Treatment of Allergic Rhinoconjunctivitis